Enhanced screening protocols for Candida auris improve hospital infection control

Mount Sinai researchers have enhanced hospital screening protocols for Candida auris, an often-drug-resistant fungal pathogen the Centers for Disease Control and Prevention considers an urgent global health threat.

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination | Psychedelic Invest

TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development

August 30, 2024

Blue Earth and Seibersdorf to link on radiopharmaceuticals

The deal expansion aims to ensure a future supply of the therapeutic radiopharmaceutical for clinical trial sites in the UK, EU and US. Credit: IM

August 12, 2024

Empathy should be the first response to people with vaccine injury, fears

For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to write off the concerns of

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.